Why Is Ionis Pharmaceuticals (IONS) Down 5.8% Since Last Earnings Report?
nasdaq.com
news
2022-06-03 11:31:00

It has been about a month since the last earnings report for Ionis Pharmaceuticals (IONS). Shares have lost about 5.8% in that time frame, underperforming the S&P 500.

Will the recent negative trend continue leading up to its next earnings release, or is Ionis Pharmaceuticals due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.

Q1 Earnings & Revenues Beat Estimates

Ionis reported first-quarter 2022 loss of 46 cents per share, narrower than the Zacks Consensus Estimate of a loss of 68 cents.
